Ledger.
Investor · Newton, MA

Paul Ashton

Open Paul in the network graph →
Filings
9
SEC Form D
Connections
31
co-filers
Capital
$9.0M
across filings
Active
Jan 2022
to Mar 2025

Most-connected co-filers (31)

Balamurali U. Ambati · Salt Lake City, UT7 sharedNapoleone Ferrara · Newton, MA5 sharedMichele Zimba · Eugene, OR3 sharedMary Weber · Newton, MA3 sharedAdam Kall · Marquette, MI3 sharedJames Shephard · Eugene, OR3 sharedJayakrishna U. Ambati · Salt Lake City, UT3 sharedStephen Zimba · EUGENE, OR3 sharedKenneth Epps · EUGENE, OR3 sharedJoon Lee · Newton, MA3 sharedAustin Morris · Marquette, MI3 sharedLawrence B. Rodman · New York, NY2 sharedKen Hight · St. Andrews, New Brunswick, Canada2 sharedMichael Beattie · St. Andrews, Ontario, Canada2 sharedEzra Kwok · St. Andrews, Ontario, Canada2 sharedJason Brahms · Studio City, CA2 sharedDean Shalit · Encino, CA2 sharedBlair H. Wallace · New York, NY2 sharedBrett H. Lipsky · New York, NY2 sharedMitchell Snyder · Las Vegas, NV2 sharedCassandra Snyder · Las Vegas, NV2 sharedShawn Griffith · Denton, TX2 sharedChristie Schofield · Seattle, WA1 sharedMikhail Kaufman · Murphy, TX1 shared

Recent filings (9)

2800 W Pioneer Partners LLCJul 2025 · 9 co-filers$4.3MInflammasome Therapeutics, Inc.Mar 2025 · 17 co-filers$10.0MInflammasome Therapeutics, Inc.Mar 2025 · 17 co-filers$10.0MEdit Hero, Inc.Jul 2024 · 7 co-filers$1.0MInflammasome Therapeutics, Inc.Jan 2024 · 17 co-filers$3.8MInflammasome Therapeutics, Inc.Jan 2024 · 17 co-filers$3.8M805 CENTRAL PARTNERS LLCAug 2023 · 8 co-filers$13.0MInflammasome Therapeutics, Inc.Aug 2023 · 17 co-filers$3.8MInflammasome Therapeutics, Inc.Aug 2023 · 17 co-filers$3.8MGIS Ventures Inc.Jan 2022 · 8 co-filers$700KGIS Ventures Inc.Jan 2022 · 8 co-filers$42KEdit Hero, Inc.Jan 2022 · 7 co-filers$1.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Paul in the interactive graph →